< Back to Data collection & documentation
Authors
Webbe J, Lack N, Daly M, Göpel W, Helenius K, Latour J, Modi N, Soll R, Wills-Eve B
Infants and parents
Healthcare professionals, neonatal units, hospitals, and health services
Recording, collating and reporting quality indicators in a standardised manner supports comparisons of care nationally, within Europe and beyond.
The care provided to neonates affects outcomes in every organ system (1) with implications that extend through childhood (2), into adult life (3), and may affect an individual’s offspring. (4) Admission to a neonatal unit also affects parents and the wider family. (5–7) Valid, reliable quality indicators are needed to ensure that the care provided to neonatal patients is evidence-based, of the highest standards, and leads to positive long-term outcomes.
Quality indicators are standardised, evidence-based measures to monitor and evaluate the process, performance or outcomes of neonatal care delivery. (8,9) Recording and reporting these indicators in a standardised manner allows audit, benchmarking, quality improvement, service evaluation and research across Europe: this allows greater understanding of the variation in care provision and outcomes currently seen within (10–12) and between countries. (13,14) The European Standards of Care for Newborn Health (ESCNH) quality indicators identified in this standard include background characteristics required for risk-adjustment (15,16), process measures (17), and neonatal outcomes. (18)
Within Europe, there are a number of regional, national and international databases holding data relating to quality indicators; but coverage is not universal and data are not always comparable between databases. (19) Expanding the coverage of existing databases and creating new databases (where necessary) allows international data combination and comparison. Data should be recorded using standard nomenclatures and internationally recognised terminologies. Ideally, individual data components are captured to allow the application of multiple indicator definitions to ensure meaningful comparisons can be made. For example, by capturing data reporting duration of different modes of ventilation any selected definition of bronchopulmonary dysplasia could be applied across multiple databases. (20) The creation of pan-European databases to improve neonatal care should be compatible with existing international projects (such as the NNRD, eNewborn, iNeo and the Vermont Oxford Network). Comparing quality indicators internationally helps identify optimal practice within Europe, highlights practice deficits, and ensures continued improvement in neonatal outcomes. (21)
For parents and family
A (High quality)
Audit report1, parent feedback
B (Moderate quality)
Audit report1
A (High quality)
Audit report1, parent feedback, patient information sheet
A (High quality)
Parent feedback
For healthcare professionals
B (Moderate quality)
Guideline
B (Moderate quality)
Training documentation
For neonatal unit
A (High quality)
Audit report1
B (High quality)
Audit report1
For hospital
A (High quality)
Audit report1
A (High quality)
Audit report1, regional network
For health service
A (High quality)
Audit report1
A (High quality)
Policy statement
A (High quality)
Guideline
B (High quality)
Policy statement
1The indicator ‘audit report’ can also be defined as a benchmarking report.
For parents and family
A (High quality)
A (High quality)
B (Moderate quality)
For healthcare professionals
A (High quality)
For neonatal unit
A (High quality)
A (High quality)
For hospital
B (High quality)
B (Moderate quality)
A (Moderate quality)
For health service
B (High quality)
A (Moderate quality)
B (High quality)
A (High quality)
A (High quality)
For parents and family
For healthcare professionals
For neonatal unit
For hospital
For health service
Quality indicators
The European Standards of Care for Newborn Health (ESCNH) quality indicators are variables required for collection and reporting of standardised data. They include background variables required for extensive risk-adjustment, process measures and important neonatal outcomes. The variables have been derived from: a systematic review of existing databases (19), a systematic review of the background characteristics reported in clinical trials (15), international consensus projects (18,30), and the variables included in validated prognostic models. (16)
These indicators should be recorded and reported using standard nomenclature, in line with internationally recognised terminology. However, we acknowledge that for most quality indicators no global consensus exists as to the ‘perfect’ definition or measurement tool (37–39): instead, we propose that capturing individual data components using recognised, validated definitions will provide the flexibility needed to apply different definitions to the data and facilitate meaningful comparisons between databases. It is also essential that suitable denominator data are available to allow meaningful comparison between populations: for this to occur demographic data relating to all live births, defined according to the AAP definition (40), should be available.
Timing of assessment and data collection is important: as a minimum, it should be in line with standardised assessments, but collecting and recording more frequent data will facilitate the application of multiple definitions. Furthermore, some of the indicators include long-term outcomes. The impact of preterm birth has been clearly shown to extend throughout childhood and into adult life and so, outcomes should be collected into adulthood. To achieve this, collaboration will be needed to ensure that data can be linked between different databases. This work is now possible because data capture and storage technologies are improving and international collaborations are expanding allowing maximal use of available data. Future work to establish a European database will create a tiered structure of responsibility at regional, national and pan-national levels.
Indicator | Suggested data components |
Background characteristics | |
Maternal factors | |
Antenatal care | 1. Whether the mother accessed antenatal care (see Birth & transfer) |
Antenatal steroid exposure | 2. Type of steroids 3. Date and time of doses |
Barriers to care | 4. Whether any barriers exist preventing patients from accessing antenatal or neonatal care (e.g. cultural, financial) |
Maternal age | 5. Maternal age in years at birth |
Maternal complications of pregnancy | 6. Reported using standardised terminology according to an accepted definition |
Maternal drug use | 7. Drug use status at first antenatal contact (including prescribed medications and illicit substances) 8. Use of drugs during pregnancy |
Maternal education | 9. Reported using standardised terminology according to an accepted definition |
Maternal ethnicity | 10. Reported using standardised terminology according to an accepted definition |
Maternal medical problems | 11. Reported using an accepted definition |
Maternal smoking status | 12. Smoking status at first antenatal contact 13. Number of cigarettes smoked during pregnancy |
Maternal socio-economic status | 14. Reported using standardised terminology according to an accepted definition |
Labour and delivery | |
Duration of rupture of membranes | 15. The time from rupture of membranes to birth |
Highest maternal temperature during labour | 16. The highest recorded maternal temperature during labour |
Location of delivery: maternity | 17. The level of maternity care provided at the location of delivery |
Location of care: neonatal | 18. The level of neonatal care provided at the location of delivery (see Birth & transfer) |
Mode of delivery | 19. Reported using standardised terminology according to an accepted definition |
Presentation of foetus at delivery | 20. Presentation prior to delivery |
Infant factors | |
1 minute Apgar score | 21. Apgar score one minute after birth |
Birth weight | 22. Birth weight at the time of delivery in grams |
Congenital anomaly | 23. Reported using standardised terminology according to an accepted definition |
Gestational age | 24. Gestational age at birth of neonate in whole weeks and remaining days |
Plurality | 25. Number of foetuses during pregnancy |
Sex | 26. Phenotypic sex of neonate |
Process measures | |
Delayed cord clamping | 27. Duration from live birth to cord clamping |
Family-centred care | 28. Reported using standardised terminology according to an accepted definition (see Infant- & family-centred developmental care) |
Feeding during admission | 29. Timing of feeding 30. Route of feeding 31. Choice of milk 32. Volume of milk (see Nutrition) |
Long-term follow up | 33. Whether a neonate received appropriate long-term follow up (see Follow-up & continuing care) |
Minimising inappropriate separation | 34. Whether a neonate was separated from their mother without clinical indication (see Infant- & family-centred developmental care) |
Nurse staffing ratios | 35. Whether the neonate received a suitable level of nursing care throughout their stay (see Patient safety & hygiene practice) |
Parenteral nutrition | 36. Whether the neonate received parenteral nutrition 37. Formulation of parenteral nutrition 38. Route of parenteral nutrition 39. Duration of parenteral nutrition (see Nutrition) |
Screening for retinopathy of prematurity | 40. Whether the neonate underwent screening for retinopathy of prematurity (if indicated) 41. Timing of screening for retinopathy of prematurity (see Medical care & clinical practice) |
Surfactant administration | 42. Doses of surfactant received 43. Formulation of surfactant 44. Route of surfactant |
Outcomes | |
Adverse events | 1.Any harm from care during the neonatal period reported using standardised terminology according to an accepted definition |
Brain injury (on imaging) | 2. Timing of scans 3. Pathology seen on scan, reported using standardised terminology according to an accepted definition |
Chronic lung disease/bronchopulmonary dysplasia | 4. Mode of respiratory support 5. Duration of respiratory support |
General cognitive ability | 6. Timing of milestones 7. Timing and results of testing, reported using standardised terminology according to an accepted definition |
General gross motor ability | 8. Timing of milestones 9. Timing and results of testing, reported using standardised terminology according to an accepted definition |
Hearing impairment or deafness | 10. Timing of hearing tests 11. Results of hearing tests |
Necrotising enterocolitis | 12. Timing and results of relevant biochemical and radiological testing 13. Clinical features 14. Timing and findings at surgery |
Pain | 15. Reported using standardised terminology according to an accepted definition |
Pulmonary function | 16. Reported using standardised terminology according to an accepted definition |
Quality of life | 17. Reported using standardised terminology according to an accepted definition |
Retinopathy of prematurity | 18. Timing and results of screening 19. Timing and mode of therapy |
Sepsis | 20. Timing and results of relevant biochemical and microbiological testing 21. Clinical features |
Social functioning | 22. Reported using standardised terminology according to an accepted definition |
Survival | 23. Timing of death 24. Survival to discharge home |
Visual impairment or blindness | 25. Timing of vision tests 26. Results of vision tests |
September 2022 / 1st edition / next revision: 2025
Recommended citation
EFCNI, Webbe J, Lack N et al., European Standards of Care for Newborn Health: Quality indicators. 2022.